| Volume: | NA |
|---|---|
| Day's Low: | NA |
| 52-wk Low: | $44.45 |
| Previous Close: | $57.30 |
| Dividend: | $0.10 |
| Market Cap: | 10,252,000 |
| Avg Volume: | 1,322,600 |
|---|---|
| Day's High: | NA |
| 52-wk High: | $62.83 |
| Open Price: | NA |
| Yield: | 0.70% |
| P/E (Forward): | 13.61 |
| 4:14 PM | 3/12/2010 | 2nd UPDATE: FDA Adds Boxed Warning To Plavix On Effectiveness |
| 8:55 AM | 10/20/2009 | Quest Diagnostics 3Q Profit Climbs 74% On Strong Demand |
| 3/19/2010 | CAPS investors eagerly adopt this caregiving company. (The Motley Fool) |
| 3/13/2010 | FDA Adds Warning to Plavix (WSJ.com) |
| 3/9/2010 | Collecting the Right Set of Blue-Chip Stocks (Barrons.com) |
| 3/8/2010 | New Ovarian-Cancer Test (WSJ.com) |
| 2/26/2010 | Why you should love stocks that are going nowhere fast. (The Motley Fool) |
| 1/25/2010 | H-P, Microsoft Climb; Apple Tacks On 2.7% (WSJ.com) |
| 1/25/2010 | Quest Diagnostics Earnings for the Fourth Quarter Rises 6.9% (Fox Business) |
| 1/25/2010 | Afternoon Movers: Goldman et al Buck Regulation Fears; Halliburton Falls, Steel Makers Rise (Barrons.com) |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.97 | 0.87 | 11.49 |
| EPS, GAAP | 0.97 | 0.87 | 11.49 |
| Consensus Estimate | 0.96 | 0.80 | 20.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.88 | 3.87 | 0.26 |
| EPS, GAAP | 3.87 | 2.96 | 30.74 |
| Consensus Estimate | 3.68 | NA | NA |
| DGX | Industry Average | |
| P/E (TTM) | 14.81 | 22.60 |
| P/E (Forward) | 13.61 | 11.60 |
| PEG Ratio | 1.11 | 0.73 |
| Price/Sales | 1.44 | 1.75 |
| Beta | 0.40 | 0.47 |